Skip to main content
OpenTrials
Completed

NCT Number: NCT05485337

Effectiveness of Therapeutic Tactics of Analgesia in Patients With Gunshot and Mine-explosive Wounds at the Stages of Treatment

In 82.1% of patients with gunshot and mine-explosive wounds, pain becomes chronic, therefore, the study of the effectiveness of therapeutic tactics for pain relief in this category of patients at the stages of treatment will be important for improving the results of pain treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Pain Agnosia Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Perceptual Disorders Signs and Symptoms Wounds and Injuries

Sex eligibility

Male

Study type

Observational

Primary location

Bogomolets National Medical University, Ministry of Health of Ukraine

Kyiv, Ukraine

About this study

The effectiveness of the therapeutic tactics of analgesia in patients with gunshot and mine-explosive wounds at the stages of treatment needs to be studied, because the subjective feelings and emotional experiences experienced by patients during the wounding in combat conditions through the prism of psychological disorders have their own characteristics. Given that in 82.1% of cases it is not possible to achieve a positive result of treatment, the data of our study will play an important role in their treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • the presence of gunshot wounds

Exclusion criteria

  • no gunshot wounds

Treatment and study plan

Visual analog scale

Other

Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.

Other names: neuropathic pain Didier Bouhassiraa, Nadine Attala et al. Pain, 2005, 114: 29-36 (DN4)., Chaban Quality of Life Scale, The Hospital Anxiety and Depression Scale (HADS), Mississippi PTSD scale (military version)

Primary outcomes

  1. visual analog scale

    Time frame: 12 months

    from 0 to 10 points

  2. Didier Bouhassiraa DN4

    Time frame: 12 months

    4 or more points (a neuropathic pain component is present)

  3. The Hospital Anxiety and Depression Scale

    Time frame: 12 months

    0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity

  4. Chaban Quality of Life Scale

    Time frame: 12 months

    up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high

  5. Mississippi PTSD scale (military version)

    Time frame: 12 months

    the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD

Sponsors and collaborators

Lead sponsor

Bogomolets National Medical University

Other

Registry information

Acronym: ETTAPGM-EWST

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Aug 3, 2022
Registry last updated
Aug 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.